BRIEF published on 04/08/2025 at 07:05, 11 months 24 days ago BioVersys présentera les données du BV100 à l'ESCMID Global 2025 Essai Clinique Résistance Aux Antibiotiques BV100 BioVersys ESCMID 2025
BRIEF published on 04/08/2025 at 07:05, 11 months 24 days ago BioVersys to Showcase BV100 Data at ESCMID Global 2025 Clinical Trial Antibiotic Resistance BV100 BioVersys ESCMID 2025
PRESS RELEASE published on 04/08/2025 at 07:00, 11 months 24 days ago BIOVERSYS TO PRESENT BV100 PHASE 2 DATA AT 35TH ESCMID GLOBAL 2025 BioVersys to present BV100 Phase 2 data at 35th ESCMID Global 2025. Oral presentation on positive VABP trial read-out & poster presentations on Acinetobacter baumannii & NTM data Clinical Data BV100 Antibacterial Products BioVersys ESCMID Global 2025
BRIEF published on 03/31/2025 at 07:05, 1 year ago BioVersys Secures Chinese Patent for BV100 Technology Chinese Market BioVersys AG BV100 Patent Acinetobacter Infections Rifabutin Formulation
BRIEF published on 03/31/2025 at 07:05, 1 year ago BioVersys obtient un brevet chinois pour la technologie BV100 Marché Chinois BioVersys AG Brevet BV100 Infections À Acinetobacter Formulation De Rifabutine
PRESS RELEASE published on 03/31/2025 at 07:00, 1 year ago BIOVERSYS ANNOUNCES IMPORTANT BV100 PATENT GRANTED BY CHINESE PATENT OFFICE BioVersys AG announces the granting of an important BV100 patent by the Chinese Patent Office, protecting novel drug candidate technology Patent China BioVersys AG BV100 Antibacterial
BRIEF published on 03/26/2025 at 07:05, 1 year ago BioVersys présente ses réalisations et ses résultats financiers pour 2024 Résultats Financiers 2024 Succès De L'introduction En Bourse BioVersys AG Essai BV100 Études Sur L'Alpibectir
BRIEF published on 03/26/2025 at 07:05, 1 year ago BioVersys Outlines 2024 Achievements and Financials 2024 Financials IPO Success BioVersys AG BV100 Trial Alpibectir Studies
PRESS RELEASE published on 03/26/2025 at 07:00, 1 year ago BIOVERSYS REPORTS CORPORATE HIGHLIGHS AND KEY FINANCIALS FOR THE FULL YEAR 2024 BioVersys AG reports corporate highlights and key financials for the full year 2024 including successful IPO on SIX Swiss Exchange, Phase 2 trial results, and financial activities Financial Results Clinical Trials IPO Operating Income BioVersys AG
BRIEF published on 03/19/2025 at 07:05, 1 year ago Premier patient traité dans le cadre de l'essai Alpibectir-Éthionamide contre la tuberculose Essai De Phase 2 Collaboration GSK BioVersys Alpibectir-Ethionamide Tuberculose
Published on 04/02/2026 at 15:00, 2 hours 13 minutes ago Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 2 hours 33 minutes ago Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 2 hours 43 minutes ago Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/02/2026 at 14:10, 3 hours 3 minutes ago Side-by-Side Conference Hosts Close to 800 Participants in Malta to Advance Women's Health Care
Published on 04/02/2026 at 14:00, 3 hours 13 minutes ago Electrovaya Collaborates on U.S. Department of Energy-Funded Project to Advance Energy Storage for Critical Infrastructure
Published on 04/02/2026 at 16:10, 1 hour 3 minutes ago The Adelaïde Group continued on its growth path in 2025 and consolidated the foundations of its European expansion
Published on 04/02/2026 at 15:32, 1 hour 40 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 04/02/2026 at 15:31, 1 hour 41 minutes ago Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 04/02/2026 at 15:30, 1 hour 42 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/02/2026 at 15:29, 1 hour 43 minutes ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited
Published on 04/02/2026 at 09:00, 8 hours 13 minutes ago STEF : Avis de mise à disposition des comptes annuels 2025
Published on 04/02/2026 at 08:30, 8 hours 43 minutes ago Edenred and EnBW partner to simplify electric fleet management in Germany
Published on 04/02/2026 at 08:30, 8 hours 43 minutes ago Edenred et EnBW s'associent pour simplifier la gestion des flottes électriques en Allemagne
Published on 04/02/2026 at 08:05, 9 hours 8 minutes ago Neoen announces the launch of France's largest battery
Published on 04/02/2026 at 08:05, 9 hours 8 minutes ago Neoen annonce le lancement de la plus grande batterie de France
